United States · How much has NextRNA Therapeutics raised?
NextRNA Therapeutics has raised $47M across 1 round since 2022.
United States · Series A startup
Who invested in NextRNA Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow NextRNA Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$47Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $47MMar 2022
- Investors
- 0
The rounds
- Mar 2022Series A$47M
No investor was named in the report.
Source recordedSEC filing: $23M sold, first sale Jan 2022
Funding filed with regulators
NextRNA Therapeutics filed one raise, $23M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jan 2022$23MSEC Form D
Founders and team
From the SEC filings it signed: 2 on the team.
- Julia A. NovinaExecutive Officeri
- Marc A. CohenExecutive Officer, Directori
On the board, as filediAlain A. CohenAndrea A. ArmstrongArthur A. BeckerBarry A. PoliskyCarl A. NovinaChristine A. HendersonDominique A. VerhelleDrew A. DennisonElena A. ProkupetsFred A. MermelsteinKenneth A. AndersonMalcolm A. SalterSusan A. Langer
Quick answers about NextRNA Therapeutics
When did NextRNA Therapeutics last raise?
NextRNA Therapeutics's most recent round was a Series A of $47M in Mar 2022.
What was NextRNA Therapeutics's biggest round?
Its most recent round, $47M in Mar 2022, is also its largest on record.
What stage is NextRNA Therapeutics at?
NextRNA Therapeutics's latest named round is a Series A, in Mar 2022.
Where is NextRNA Therapeutics based?
NextRNA Therapeutics is based in the United States.
Companies like NextRNA Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.